Press Room

The company will present data on investigational cancer drugs such as figitumumab, a monoclonal antibody for lung cancer, as well as Sutent (sunitinib) and the kidney cancer drug axitinib, as well as drugs for lymphoma and others.

Each of this years 46 awardees will receive a 1-year grant of $50,000 to fund his or her investigative studies as they begin their careers in clinical oncology research. The Kidney Cancer Association is pleased to be a collaborator in funding these important grants.

The researchers identified a pair of proteins -- aquaporin-1, or AQP1, and adipophilin, or ADFP, -- that are excreted in the urine that could lead to earlier and more accurate diagnosis of the disease. The proteins were not elevated in people without cancer.

The treatment paradigm in advanced renal cell carcinoma (RCC) has changed in the recent years. Sunitinib has been established as a new standard for first-line therapy. We studied the prognostic significance of baseline characteristics and we compared the risk stratification with the established Memorial Sloan Kettering Cancer Center (MSKCC) model.

Individuals involved in the management of patients with small renal masses should acknowledge the role and the importance of active surveillance in older populations (aged >75 years) and minimally invasive ablative therapies. These new therapeutic strategies should be inculcated during medical training and practice so that they may become just as embedded as the emphasis on the oncologic outcome of standard treatment.